INNO-LIA® HIV I/II Score
The clearest answer in HIV confirmation
Line immunoassay for the confirmation and discrimination of antibodies to HIV-1, HIV-1 group O and HIV-2 in human serum and plasma.
Product number 80540
Click here to navigate
- Conditions of sale
- Related products
- Product inquiry
Features & Benefits
- All major HIV strains detectable with one strip: HIV-1, HIV-2, and HIV-1 group O
- Optimal specificity in screened-negative blood donors: 96.7% (290/300)
- High sensitivity in BBI panels
- Short and overnight procedures
- Color-coded reagents
- Ready-to-use reagents
- Four control lines to monitor 1) non-specific reactivity, 2) sample addition, 3) and 4) color development steps
- Fully automated strip processing possible using TENDIGO™, Auto-LIA™ 48, Auto-LiPA™ 48 or AutoBlot 3000(H)
- Objective, automated reading and interpretation of the strips possible using LiRAS® for Infectious Diseases
Antibodies to human immunodeficiency virus (HIV) have been detected in most patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC), and in many asymptomatic individuals belonging to high-risk groups. Enzyme-linked immunosorbent assays (ELISA) are widely used to screen human blood and plasma samples for the presence of these HIV antibodies.
However, since false-positive reactions have frequently been observed with current ELISA tests, it is strongly recommended to confirm repeatedly reactive samples by use of other reliable techniques (such as the INNO-LIA HIV I/II Score). Recombinant proteins and synthetic peptides from HIV-1 and HIV-2, and a synthetic peptide from HIV-1 group O, are coated as discrete lines on a nylon strip with plastic backing.
The INNO-LIA HIV I/II Score assay contains sequences derived from HIV-O sequences to allow the optimal detection of infections caused by this group of viruses. To allow the broad spectrum detection of all HIV infections, the INNO-LIA HIV I/II Score assay also contains separate lines for the differentiation of HIV-1 and HIV-2 infections.
This is important, as HIV-2 is less virulent, resulting in a better prognosis for the patient.
Conditions of sale
To read the end user conditions of sale for this product please visit our Resource center.
How does the coronavirus disease Covid-19 impact Fujirebio's operations?
Please see the following statement on the impact of coronavirus disease Covid-19 on the operations of Fujirebio Europe (updated January 19, 2021).
INNO-LIA® HCV Score
Product number 80538 -
Line immunoassay for the detection of antibodies to human hepatitis C virus in human serum and plasma.CE marked
INNO-LIA® HTLV I/II Score
Product number 80541 -
Line immunoassay for the confirmation and discrimination of antibodies to Human T-cell Lymphotrophic Virus type I (HTLV-I) and type II (HTLV-II) in human serum and plasma.CE marked
INNO-LIA® Syphilis Score
Product number 80542 -
Line immunoassay for the confirmation of antibodies to Treponema pallidum in human serum and plasma.CE marked
LiRAS® for Infectious Diseases
Product number 80361 -
Objective reading and interpretation of INNO-LIA® strips for infectious diseases.CE marked
Product number 80629 -
Our Auto-LIA 48 offers fully automated processing for the complete range of INNO-LIA tests from sample incubation to color development, ensuring ease, speed, and confidence.CE marked
Product number 80628 -
Offers fully automated processing for the complete range of INNO-LiPA and INNO-LIA tests from hybridization to color development.CE marked
Product number 80745 -
Fully automated processing of INNO-LIA® tests from sample pipetting to strip reading and LiRAS® interpretation**, transforming tedious manual work into a completely automated throughput of high testing volumes, ensuring ease of use, chain of custody (Pos ID), and consistent performanceCE marked